Together, these results suggest that IcsB inhibits innate immune responses in two distinct ways, first, by inhibiting LC3-associated phagocytosis and/or LC3 recruitment to vacuolar membrane fragments early during infection, and second, by inhibiting autophagy late during infection. The gene discussed is MAP1LC3A; the disease is infection.